Antisoma Research Limited

Calculating rank

USPTO Granted Patents = 4

% Expired Patents = 25.0

Forward Citations = 25

Loading Chart...

9 inventors (with patents filed for the assignee):

Kin-Ming Lo (1 out of 40 patents)

Paula J Bates (1 out of 18 patents)

Donald Miller (1 out of 12 patents)

4. Yan Lan (1 out of 6 patents)

5. Rakesh Verma (1 out of 1 patent)

6. John Olaf Trent (1 out of 33 patents)

7. Alan William John Stuttle (1 out of 1 patent)

8. Stephen D Gillies (1 out of 74 patents)

9. Alan William Stuttle (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 8420087 - Interleukin-12 targeted to oncofoetal fibronectin (2013-04-16),

2. 7314926 - Antiproliferative activity of g-rich oligonucleotides and method of using same to bind to nucleolin (2008-01-01),

3. 6217846 - Synthetic peptides for use in thrombus detection (2001-04-17),

4. 5843402 - Synthetic peptides for use in thrombus detection (1998-12-01),

Company Overview

Antisoma Research Limited is a biopharmaceutical company focused on the development of innovative cancer therapies. The company specializes in targeting specific molecular pathways involved in cancer growth and progression. With a strong pipeline of novel drug candidates, Antisoma is dedicated to bringing new treatment options to patients in need.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

4 Patents

#354 in

#3,873 in United Kingdom

GB